Kura Oncology Inc (KURA): Next-Year EPS Estimate 25.54%
As of 2026-11-12, Kura Oncology Inc (KURA) has a next-year EPS growth estimate of 25.54%. Featured in 2 EPS revision reports, most recently on 2026-08-19.
On 2026-11-11, analyst consensus for KURA's next-year EPS growth shifted from 25.40% to 25.54% — a positive change of 0.14 percentage points. The revised estimate has been sustained across 2 subsequent trading sessions. Current-year growth is projected at -1.96%.
What's Driving This
The primary structural driver is the 202
Generated 2026-11-05 from news as of 2026-11-05
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 25.54%
- EPS growth this year
- -1.96%
- EPS next quarter (est)
- -$0.82
- Last price
- $7.73
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-11-12 | 25.54% | -1.96% | -$0.82 | $7.73 |
| 2026-11-11 | 25.54% | -1.96% | -$0.82 | $7.73 |
| 2026-11-10 | 25.40% | -2.29% | -$0.82 | $7.57 |
| 2026-11-09 | 25.38% | -1.91% | -$0.82 | $7.57 |
| 2026-11-07 | 25.38% | -1.91% | -$0.82 | $7.27 |
| 2026-11-06 | 25.38% | -1.91% | -$0.82 | $7.27 |
| 2026-11-05 | 25.38% | -1.91% | -$0.82 | $6.80 |
| 2026-11-04 | 25.37% | -2.31% | -$0.82 | $7.61 |
| 2026-11-03 | 25.38% | -1.91% | -$0.82 | $9.88 |
| 2026-11-02 | 25.38% | -1.91% | -$0.82 | $9.79 |
| 2026-10-31 | 25.38% | -1.91% | -$0.82 | $10.26 |
| 2026-10-30 | 25.38% | -1.91% | -$0.82 | $10.26 |
| 2026-10-29 | 25.37% | -2.04% | -$0.82 | $10.56 |
| 2026-10-28 | 25.35% | -2.12% | -$0.82 | $10.72 |
| 2026-10-27 | 25.35% | -2.12% | -$0.82 | $9.90 |
| 2026-10-26 | 25.35% | -2.12% | -$0.82 | $9.62 |
| 2026-10-23 | 25.35% | -2.12% | -$0.82 | $9.61 |
| 2026-10-22 | 25.35% | -2.12% | -$0.82 | $9.86 |
| 2026-10-21 | 25.35% | -2.12% | -$0.82 | $9.88 |
| 2026-10-20 | 25.35% | -2.12% | -$0.82 | $9.98 |
| 2026-10-19 | 25.35% | -2.12% | -$0.82 | $9.36 |
| 2026-10-16 | 25.35% | -2.12% | -$0.82 | $9.08 |
| 2026-10-15 | 25.35% | -2.12% | -$0.82 | $9.70 |
| 2026-10-14 | 25.35% | -2.12% | -$0.82 | $9.61 |
| 2026-10-13 | 25.38% | -0.93% | -$0.81 | $9.83 |
| 2026-10-12 | 25.38% | -0.93% | -$0.81 | $10.40 |
| 2026-10-11 | 25.36% | -1.34% | -$0.81 | $10.60 |
| 2026-10-10 | 25.36% | -1.34% | -$0.81 | $10.60 |
| 2026-10-09 | 25.36% | -1.34% | -$0.81 | $10.60 |
| 2026-10-08 | 25.36% | -1.34% | -$0.81 | $10.52 |
Reports Featuring KURA
Recent News
- Kura Oncology Narrows Loss And Beats As KOMZIFTI Launch Builds, But Collaboration Cut, Dilution, And Debt Shape A Battered Stock's SetupEarnings Whispers
- Kura Oncology: Q3 Earnings SnapshotAssociated Press
- Kura Oncology Reports Third Quarter 2026 Financial Results and Corporate UpdateGlobeNewswire
- Kura spins diabetes work into a Lilly-backed biotech startupBioPharma Dive
- Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for DiabetesGlobeNewswire
- Kura Oncology Appoints Jennifer Fulk as Chief Financial OfficerGlobeNewswire
- Kura Oncology, Inc. Q2 2026 Earnings Call SummaryMoby
- Kura Oncology: Q2 Earnings SnapshotAssociated Press
- Kura Oncology Reports Second Quarter 2026 Financial ResultsGlobeNewswire
- Kura Oncology to Present First Long-Term Follow-Up Data Further Supporting Darlifarnib's Potential to Enhance VEGFR-Targeted Therapy in Renal Cell Carcinoma at KCRS 2026GlobeNewswire
Screen Performance
Aggregate stats across all 2145 tickers our top-EPS-revision screen has flagged over the past 225 days.
- Median return since detection
- -2.9%
- % of tickers in the green
- 43%
- Median return on winners
- +22.8%
- Large revisions captured
- 2246
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Kura Oncology Inc's next-year EPS growth estimate?▾
As of 2026-11-12, Kura Oncology Inc (KURA) has a next-year EPS growth estimate of 25.54%, based on analyst consensus.
When was the latest EPS estimate revision for KURA?▾
The most recent revision occurred on 2026-11-11, when analysts adjusted the next-year EPS growth estimate from 25.40% to 25.54%.
What sector and industry does Kura Oncology Inc belong to?▾
Kura Oncology Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. KURA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Kura Oncology Inc (KURA) appears here because it was detected by our daily top-EPS-revision-performer screen.